Malignant Melanoma
📧 Sign up to get email alerts when something new happens for Malignant Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Post-Operative Drainage Following Lymph Node Dissection [Phase 4]
A Phase 4 clinical trial evaluated post-operative drainage following lymph node dissection in patients with malignant melanoma and squamous …
-
FDA approval · 2011-06-03FDA Approved: TEMODAR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Temodar (temozolomide) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2011-03-25FDA Approved: YERVOY — Original Application (E.R. Squibb & Sons, L.L.C.)
FDA approved YERVOY (ipilimumab) under the original application from E.R. Squibb & Sons for the treatment of malignant melanoma.
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)
This trial update reports results from Study P04083 evaluating high-dose interferon alfa-2b (Intron A) as adjuvant therapy for malignant mel…
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients [Phase 2]
Phase 2 clinical trial update evaluating the safety and immunogenicity of CYT004-MelQbG10 vaccine with and without adjuvant in advanced mali…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Imexon in combination with dacarbazine (DTIC) for advanced malignant melanoma, focusing on s…
-
CLINICAL_TRIALS research · 2010-08-11Clinical Trial Update: International Melanoma Algorithm Training Study - IMATS [NA]
A completed clinical trial update for the IMATS international melanoma algorithm training study sponsored by SciBase AB. The study concerns …
-
FDA label_change · 2010-07-06FDA Approved: PROLEUKIN — Supplemental Application (Iovance Biotherapeutics, Inc)
FDA approved a supplemental application for PROLEUKIN (aldesleukin) submitted by Iovance Biotherapeutics, Inc.
-
CLINICAL_TRIALS research · 2010-06-25Clinical Trial Update: Quality of Life and Psychological Well-being in Patients With Malignant Melanoma [NA]
This document provides an update on a clinical trial assessing quality of life and psychological well-being in patients with malignant melan…
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma [Phase 1]
This update reports the completion of a Phase 1 study of MDX-010 in patients with unresectable stage III or stage IV malignant melanoma.
-
CLINICAL_TRIALS other · 2010-02-05Clinical Trial Update: SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma [Phase 2]
Update on a Phase 2 trial of SentoClone® for advanced malignant melanoma, comparing it to a reference treatment; the trial status is current…
-
CLINICAL_TRIALS withdrawal · 2009-09-09Clinical Trial Update: Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma [Phase 2]
A Phase 2 clinical trial evaluating interferon and lovastatin for malignant melanoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma [Phase 1]
This document reports the completion of a Phase 1 study evaluating AS1409 in patients with metastatic renal cell carcinoma or metastatic mal…
-
CLINICAL_TRIALS trial_result · 2009-06-02Clinical Trial Update: Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma [Phase 2]
Phase 2 trial evaluating thymosin alpha-1 and/or interferon alpha in combination with dacarbazine for malignant melanoma; results were poste…
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer [Phase 1]
Phase 1 study evaluating Interleukin-21 for metastatic malignant melanoma and metastatic kidney cancer has completed.
-
FDA approval · 2009-02-27FDA Approved: TEMODAR — Original Application (Merck Sharp & Dohme LLC)
FDA approved TEMODAR (temozolomide) as an original application for the treatment of malignant melanoma.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Temodar and Sutent as Therapy for Melanoma [Phase 1, Phase 2]
A phase 1/2 trial evaluating temozolomide (Temodar) and sunitinib (Sutent) for metastatic malignant melanoma; the study status is terminated…
-
CLINICAL_TRIALS research · 2008-04-01Clinical Trial Update: Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma [Phase 2]
Phase 2 safety and efficacy study of INGN 241 gene therapy in patients with in-transit malignant melanoma.
-
CLINICAL_TRIALS research · 2007-09-27Clinical Trial Update: MicroRNA Expression and Function in Cutaneous Malignant Melanoma
This clinical trial update describes research about microRNA expression and function in malignant melanoma, aiming to understand molecular m…
-
CLINICAL_TRIALS trial_result · 2007-09-20Clinical Trial Update: Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating the safety and immunogenicity of a Melan-A virus-like particle (VLP) vaccine in patients with early-stage maligna…
-
CLINICAL_TRIALS trial_result · 2007-07-10Clinical Trial Update: Clinical Study of Previously Untreated Patients With Malignant Melanoma [Phase 2]
Phase 2 clinical trial evaluating treatment in previously untreated malignant melanoma patients has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients [Phase 1, Phase 2]
Update on a completed Phase 1/2 trial evaluating an intradermal stabilized tumor mRNA vaccine in patients with malignant melanoma.
-
CLINICAL_TRIALS research · 2006-10-12Clinical Trial Update: IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma [Phase 2]
Phase 2 trial evaluating intravenous immunoglobulin (IVIG) for metastatic prostate, colon, and malignant melanoma cancers; current status is…
-
CLINICAL_TRIALS trial_result · 2006-09-19Clinical Trial Update: Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a Melan-A virus-like particle vaccine in patients with advanced malignant melanoma; th…
-
CLINICAL_TRIALS trial_result · 2006-07-28Clinical Trial Update: Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer [Phase 1, Phase 2]
An early-phase trial investigating a survivin peptide vaccine in patients with advanced melanoma, pancreatic cancer, colon cancer, and cervi…